Department of Physiotherapy, Inselspital, Bern University Hospital, Bern, Switzerland.
Department of Epidemiology, Research Line Functioning, Participation and Rehabilitation CAPHRI, Maastricht University, Maastricht, The Netherlands.
Disabil Rehabil. 2023 Jan;45(1):111-116. doi: 10.1080/09638288.2021.2022785. Epub 2022 Jan 7.
To investigate the predictive validity of the Chelsea Critical Care Physical Assessment tool (CPAx) at intensive care unit (ICU) discharge in critically ill adults for their 90-day outcomes.
This prospective clinimetric study investigated four theory-driven, a-priori hypotheses in critically ill adults recruited within 72-144 h of mechanical ventilation. The primary hypothesis was a moderate accuracy (AUROC = 0.750) in predicting residence at home within 90 days. Secondary hypotheses included discrimination between hospital discharge destinations, correlation with subsequent health-related quality of life and length of ICU stay.
We observed a good accuracy (AUROC = 0.778) of the CPAx at ICU discharge in predicting a return to home within 90 days. The CPAx score significantly increased between the discharge groups "undesirable" ≤ "rehabilitation" ≤ "home" ( < 0.001), but was not associated with 90-day health-related quality of life (physical: = 0.261, mental: = 0.193). Measured at baseline, CPAx scores correlated as expected with length of ICU stay ( = -0.443).
The CPAx at ICU discharge had a good predictive validity in projecting residence at home within 90 days and general discharge destinations. The CPAx might therefore have clinical value in prediction, though it does not seem useful to predict subsequent health-related quality of life. German Clinical Trials Register (DRKS) identification number: DRKS00012983, registered on September 20, 2017IMPLICATIONS FOR REHABILITATIONThe CPAx is a valid and reliable measurement instrument to evaluate critically ill adults' physical function and activity, in addition the CPAx might be useful to predict rehabilitation needs.The CPAx had a moderate to good predictive validity with three out of four a-priori hypotheses accepted.A CPAx score of ≥18 at critical care discharge has a sensitivity of 80% and a specificity of 70% in predicting a return to home within 90 days.The CPAx might consequently be valuable to identify critically ill adults' rehabilitation needs, to advise on their potential trajectory of recovery or to screen patients for follow-up after hospital discharge.
探讨 Chelsea 重症监护身体评估工具(CPAx)在重症监护病房(ICU)出院时对危重症成人 90 天结局的预测效度。
这项前瞻性临床研究在机械通气后 72-144 小时内招募的危重症成人中,调查了四个理论驱动的先验假设。主要假设是中等准确性(AUROC = 0.750),可预测 90 天内居家居住。次要假设包括区分医院出院去向、与随后的健康相关生活质量和 ICU 住院时间的相关性。
我们观察到,在 ICU 出院时,CPAx 对预测 90 天内返回家中的准确性较好(AUROC = 0.778)。CPAx 评分在出院组“不理想”≤“康复”≤“回家”之间显著增加(<0.001),但与 90 天健康相关生活质量无关(身体:=0.261,精神:=0.193)。在基线时测量,CPAx 评分与 ICU 住院时间呈预期相关(= -0.443)。
CPAx 在 ICU 出院时对预测 90 天内居家居住和一般出院去向具有良好的预测效力。因此,CPAx 可能具有预测价值,尽管似乎对预测随后的健康相关生活质量没有帮助。
德国临床试验注册(DRKS)编号:DRKS00012983,于 2017 年 9 月 20 日注册。
CPAx 是一种有效且可靠的测量工具,可评估危重症成人的身体功能和活动能力,此外,CPAx 可能有助于预测康复需求。
CPAx 有三个先验假设中的三个具有中等至良好的预测效力。
CPAx 在重症监护病房出院时的得分≥18,预测 90 天内返回家中的灵敏度为 80%,特异性为 70%。
因此,CPAx 可能对识别危重症成人的康复需求、为其康复轨迹提供建议或筛选患者进行出院后随访具有重要价值。